Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve care for people living with arthritis.

Services for those with musculoskeletal (MSK) conditions, including arthritis, are commissioned locally by integrated care boards (ICBs). The Department expects MSK services to be fully incorporated into integrated care system planning and decision-making.

As announced in the Get Britain Working white paper, we are delivering the joint Department for Work and Pensions, the Department of Health and Social Care, and NHS England Getting It Right First-Time (GIRFT) MSK Community Delivery Programme. With a £3.5 million funding boost, the GIRFT teams will deploy their proven Further Faster model to work with ICB leaders to further reduce MSK community waiting times, including for those with arthritis, and improve data and metrics, and referral pathways to wider support services.

We will deliver an extra 40,000 operations, scans, and appointments per week during our first year in Government, as a first step in our commitment to ensuring patients can expect to be treated within 18 weeks. The Government announced £1.5 billion of new capital investment in the Autumn Budget, including investment for new diagnostic scanners and surgical hubs. This investment in scanners will build capacity for over 30,000 additional procedures and 1.25 million diagnostic tests as they come online.

To support health and care professionals in the early diagnosis and management of rheumatoid arthritis and osteoarthritis, and in the provision of services for people living with arthritis, the National Institute for Health and Care Excellence has published expert guidance for rheumatoid arthritis and osteoarthritis, which are available, respectively, at the following two links:

https://www.nice.org.uk/guidance/ng100

https://www.nice.org.uk/guidance/ng226

The Department funds research into MSK conditions, including arthritis, through the National Institute for Health and Care Research (NIHR). Through that route, the Department spent approximately £26.3 million on MSK research in 2023/24 and £79.2 million since 2019/20. In particular, the Leeds Biomedical Research Centre aims to improve treatment for osteoarthritis. The NIHR, in collaboration with Versus Arthritis, also funds a dedicated UK Musculoskeletal Translational Research Collaboration, aligning investment in MSK translational research and creating a United Kingdom-wide ambition and focus to drive cutting edge research and improve outcomes for patients.